ストックスクリーナーアプリを入手
35.56
3.24%
-1.19
アフターアワーズ：
35.53
-0.03
-0.08%
Viking Therapeutics Inc (VKTX) 最新ニュース
Viking Therapeutics Stock (VKTX) Opinions on Positive Obesity Drug Data Release - Quiver Quantitative
What Viking Therapeutics Stock Means For Shareholders After Obesity Drug Data And $500 Million Raise - simplywall.st
VKTX 10-Q FilingsViking Therapeutics, Inc SEC 10-Q - stocktitan.net
VKTX Stock On Track To Beat LLY, NVO This Month After Obesity Drug Data — Can Viking Win Over Wegovy And Zepbound Users? - Stocktwits
Viking Therapeutics Adds Weight Loss Maintenance As Potential New Growth Driver (NASDAQ:VKTX) - Seeking Alpha
Is Viking Therapeutics (VKTX) Getting Too Rich After VK2735 Data? - finance.yahoo.com
Biotech Stocks To ResearchSeptember 25th - MarketBeat
VKTX Stock Outpaces LLY, ALT Ahead Of Earnings – Retail Eyes Breakout Ahead - Stocktwits
VKTX Form 4 FilingsViking Therapeutics, Inc SEC Form 4 - stocktitan.net
Is Viking Therapeutics, Inc. (VKTX) the Healthcare Stocks Stock Everyone's About to Talk About? - Kalkine Media
Form 424B5 Viking Therapeutics Inc For: 25 September - Investing.com India
Latham Advises on Viking Therapeutics’ Upsized US$500 Million Offering of Common Stock and Convertible Senior Notes - Legal Desire
Viking Therapeutics Soared After Its Latest GLP-1 Data. Is It Too Late to Buy? - The Motley Fool
Form 424B5 Viking Therapeutics Inc For: 25 September By Investing.com - Investing.com Canada
Viking Therapeutics Soared After Its Latest GLP-1 Data. Is It Too Late to Buy? - The Motley Fool
VKTX Stock Steady After-Hours On Positive Obesity Drug Pipeline Progress - Stocktwits
Viking Therapeutics (VKTX) Stock Looks Fully Priced Despite Its Huge Five Year Run - simplywall.st
VKTX Stock Reverses Weight-Loss Drug Gains As Viking Unveils $500M Discounted Financing - Stocktwits
VKTX Stock Lags GLP-1 Peers In July — But Viking CEO Says Its Obesity Drug Could Offer What Rivals Can’t - Stocktwits
Viking Therapeutics, Inc. (VKTX) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance
Viking Therapeutics Plunges After Upsized $500 Million Financing Prices at 16% Discount - finance.biggo.com
Viking Therapeutics Share Drop After Upsized Stock, Notes Offerings - Moomoo
One investor reportedly took a third of Viking’s share sale - au.finance.yahoo.com
Viking Therapeutics raises USD 500m to advance VK2735 obesity program - AllSci
Latham Advises on Viking Therapeutics Upsized Offering of Common Stock and Convertible Senior Notes - Latham & Watkins LLP
Viking Therapeutics Advances VK2735 Obesity Trial, Keeping VKTX in the Weight Loss Race - TipRanks
Here's Why Viking Therapeutics Shares Slumped Today - The Motley Fool
Top Biotech Stocks To Keep An Eye OnSeptember 24th - MarketBeat
Why Is Viking Therapeutics Stock Trading Down Thursday? - Benzinga
Viking Therapeutics drops 15% after $500M stock offering; Jaguar Health falls 25% without news. - Pluang
Viking Therapeutics Sinks 12% on “Upsized” $500 Million Raise - TIKR.com
Viking Therapeutics Sinks 15% After Pricing Upsized $500M Offering; Jaguar Health Tumbles 25% - finance.yahoo.com
Biggest stock movers Thursday: P, VKTX, MGM, BE, and more - Seeking Alpha
Viking Therapeutics Prices Upsized Stock and Convertible Notes Offering at Discount - Intellectia AI
VKTX Stock Heads Toward Worst Day In Over A Year Just Days After Promising Weight Loss Drug Data — Here’s What’s Driving The Selloff - Yahoo Finance
What Did Viking Therapeutics (NASDAQ:VKTX) Maintenance Data Show for VK2735? - Kalkine Media
Viking Therapeutics Prices Upsized $500 Million Stock, Convertible Notes Offering - marketscreener.com
Viking Therapeutics (VKTX) Prices $490M Concurrent Offering Amid Unprofitable Growth Outlook - GuruFocus
Why is Viking Therapeutics stock tumbling today? By Investing.com - Investing.com Canada
Stitch Fix Posts Mixed Q4 Results, Joins Viking Therapeutics And Other Big Stocks Moving Lower In Thursda - Benzinga
Why is Viking Therapeutics stock tumbling today? - Investing.com
Viking Therapeutics raises $500M in upsized stock and notes offering - Dealroom
Viking Therapeutics prices $500M stock and debt offering - Investing.com
Viking Therapeutics prices $275M stock and conv... - Pluang
Viking Therapeutics prices $500M stock and debt offering By Investing.com - ng.investing.com
Viking Therapeutics prices upsized $500M offering of common stock and convertible senior notes - TradingView
Viking Therapeutics Prices Upsized $500 Million Offering Of Common Stock And Convertible Senior Notes - TradingView
Viking Therapeutics, Inc. (VKTX) Prices Upsized $500M Stock and 2.00% Convertible Notes - TradingView
VKTX Stock Eyes Blockbuster Week Despite Share Offering — Retail Traders See A Stronger Hand In Buyout Talks - Yahoo Finance
Positive VK2735 Clinical Data: Can Viking Therapeutics Displace Eli Lilly and Novo Nordisk? - NAI500
Is Viking Therapeutics (VKTX) Fully Valued On Its Positive VK2735 Trial Update? - simplywall.st
Viking Therapeutics Plans $400 Million Public Offerings - Intellectia AI
VKTX Stock Slides After-Hours On $400M Stock-And-Notes Raise After Tuesday’s Rally - finance.yahoo.com
Viking Therapeutics, Inc. (VKTX) Discusses Top Line Data from VK2735 Maintenance Study in Obesity and Type 2 DiabetesSlideshow (NASDAQ:VKTX) 2026-09-22 - Seeking Alpha
Form 424B5 Viking Therapeutics Inc For: 23 September By Investing.com - Investing.com Canada
Viking Therapeutics (VKTX) Plans $400M Capital Raise Amid Mixed Market Signals - GuruFocus
Viking Therapeutics, Inc. (VKTX) Gains As Market Dips: What You Should Know - Yahoo Finance
Viking Therapeutics (VKTX) Plans $400M Capital Raise via Stock a - GuruFocus
Viking Therapeutics Plans Offering of Common Shares, Senior Notes due 2032 - finance.yahoo.com
Viking Therapeutics Announces Proposed Offerings Of Common Stock And Convertible Senior Notes - TradingView
3.06%
2.55%
大文字化:
|
ボリューム (24 時間):